nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ABCG2—primary biliary cirrhosis	0.366	0.696	CbGaD
Vemurafenib—ABCC1—Colchicine—primary biliary cirrhosis	0.193	0.699	CbGbCtD
Vemurafenib—ALB—primary biliary cirrhosis	0.16	0.304	CbGaD
Vemurafenib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0552	0.2	CbGbCtD
Vemurafenib—CYP3A4—Colchicine—primary biliary cirrhosis	0.0279	0.101	CbGbCtD
Vemurafenib—ORM1—bile—primary biliary cirrhosis	0.00844	0.385	CbGeAlD
Vemurafenib—Skin papilloma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00533	0.0509	CcSEcCtD
Vemurafenib—Skin papilloma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00533	0.0509	CcSEcCtD
Vemurafenib—Polyp—Ursodeoxycholic acid—primary biliary cirrhosis	0.00285	0.0273	CcSEcCtD
Vemurafenib—Polyp—Chenodeoxycholic acid—primary biliary cirrhosis	0.00285	0.0273	CcSEcCtD
Vemurafenib—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.0026	0.0248	CcSEcCtD
Vemurafenib—Cyst—Ursodeoxycholic acid—primary biliary cirrhosis	0.0026	0.0248	CcSEcCtD
Vemurafenib—ORM1—gall bladder—primary biliary cirrhosis	0.00234	0.107	CbGeAlD
Vemurafenib—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00211	0.0202	CcSEcCtD
Vemurafenib—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00211	0.0202	CcSEcCtD
Vemurafenib—ALB—gall bladder—primary biliary cirrhosis	0.00205	0.0936	CbGeAlD
Vemurafenib—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00176	0.0168	CcSEcCtD
Vemurafenib—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00176	0.0168	CcSEcCtD
Vemurafenib—Rash maculo-papular—Colchicine—primary biliary cirrhosis	0.00176	0.0168	CcSEcCtD
Vemurafenib—RAF1—epithelium—primary biliary cirrhosis	0.00176	0.08	CbGeAlD
Vemurafenib—RAF1—smooth muscle tissue—primary biliary cirrhosis	0.00169	0.0771	CbGeAlD
Vemurafenib—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.015	CcSEcCtD
Vemurafenib—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.015	CcSEcCtD
Vemurafenib—BRAF—liver—primary biliary cirrhosis	0.00149	0.0681	CbGeAlD
Vemurafenib—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.0137	CcSEcCtD
Vemurafenib—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.0137	CcSEcCtD
Vemurafenib—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.0127	CcSEcCtD
Vemurafenib—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.0127	CcSEcCtD
Vemurafenib—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.0124	CcSEcCtD
Vemurafenib—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.0124	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.00106	0.0101	CcSEcCtD
Vemurafenib—RAF1—liver—primary biliary cirrhosis	0.000995	0.0454	CbGeAlD
Vemurafenib—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000994	0.0095	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000994	0.0095	CcSEcCtD
Vemurafenib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00941	CcSEcCtD
Vemurafenib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00941	CcSEcCtD
Vemurafenib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000971	0.00928	CcSEcCtD
Vemurafenib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000971	0.00928	CcSEcCtD
Vemurafenib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000971	0.00928	CcSEcCtD
Vemurafenib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000971	0.00928	CcSEcCtD
Vemurafenib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000907	0.00866	CcSEcCtD
Vemurafenib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000874	0.00835	CcSEcCtD
Vemurafenib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000859	0.0082	CcSEcCtD
Vemurafenib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000859	0.0082	CcSEcCtD
Vemurafenib—Alopecia—Colchicine—primary biliary cirrhosis	0.000857	0.00819	CcSEcCtD
Vemurafenib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000856	0.00818	CcSEcCtD
Vemurafenib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000856	0.00818	CcSEcCtD
Vemurafenib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000844	0.00807	CcSEcCtD
Vemurafenib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000815	0.00778	CcSEcCtD
Vemurafenib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000815	0.00778	CcSEcCtD
Vemurafenib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000809	0.00773	CcSEcCtD
Vemurafenib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000809	0.00773	CcSEcCtD
Vemurafenib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000791	0.00756	CcSEcCtD
Vemurafenib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000791	0.00756	CcSEcCtD
Vemurafenib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000786	0.00751	CcSEcCtD
Vemurafenib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000786	0.00751	CcSEcCtD
Vemurafenib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000782	0.00747	CcSEcCtD
Vemurafenib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000782	0.00747	CcSEcCtD
Vemurafenib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00077	0.00736	CcSEcCtD
Vemurafenib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00077	0.00736	CcSEcCtD
Vemurafenib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000759	0.00725	CcSEcCtD
Vemurafenib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000759	0.00725	CcSEcCtD
Vemurafenib—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00701	CcSEcCtD
Vemurafenib—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00701	CcSEcCtD
Vemurafenib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000719	0.00687	CcSEcCtD
Vemurafenib—Myalgia—Colchicine—primary biliary cirrhosis	0.000719	0.00687	CcSEcCtD
Vemurafenib—ORM1—liver—primary biliary cirrhosis	0.000687	0.0313	CbGeAlD
Vemurafenib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000676	0.00646	CcSEcCtD
Vemurafenib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000669	0.0064	CcSEcCtD
Vemurafenib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000662	0.00633	CcSEcCtD
Vemurafenib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000662	0.00633	CcSEcCtD
Vemurafenib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000646	0.00617	CcSEcCtD
Vemurafenib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000646	0.00617	CcSEcCtD
Vemurafenib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000646	0.00617	CcSEcCtD
Vemurafenib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000646	0.00617	CcSEcCtD
Vemurafenib—Hypotension—Colchicine—primary biliary cirrhosis	0.000644	0.00615	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000641	0.00613	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000641	0.00613	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000628	0.006	CcSEcCtD
Vemurafenib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000615	0.00588	CcSEcCtD
Vemurafenib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000615	0.00588	CcSEcCtD
Vemurafenib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000607	0.0058	CcSEcCtD
Vemurafenib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000607	0.0058	CcSEcCtD
Vemurafenib—ALB—liver—primary biliary cirrhosis	0.000602	0.0275	CbGeAlD
Vemurafenib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000601	0.00575	CcSEcCtD
Vemurafenib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000601	0.00575	CcSEcCtD
Vemurafenib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000599	0.00572	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000595	0.00569	CcSEcCtD
Vemurafenib—Fatigue—Colchicine—primary biliary cirrhosis	0.000594	0.00568	CcSEcCtD
Vemurafenib—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000579	0.00553	CcSEcCtD
Vemurafenib—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000579	0.00553	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00539	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00539	CcSEcCtD
Vemurafenib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00514	CcSEcCtD
Vemurafenib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00514	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00511	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00511	CcSEcCtD
Vemurafenib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000534	0.0051	CcSEcCtD
Vemurafenib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000534	0.0051	CcSEcCtD
Vemurafenib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00053	0.00506	CcSEcCtD
Vemurafenib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00053	0.00506	CcSEcCtD
Vemurafenib—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000508	0.00485	CcSEcCtD
Vemurafenib—ABCC1—liver—primary biliary cirrhosis	0.000497	0.0227	CbGeAlD
Vemurafenib—Asthenia—Colchicine—primary biliary cirrhosis	0.000494	0.00472	CcSEcCtD
Vemurafenib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00468	CcSEcCtD
Vemurafenib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00468	CcSEcCtD
Vemurafenib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000472	0.00451	CcSEcCtD
Vemurafenib—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000456	0.00436	CcSEcCtD
Vemurafenib—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000456	0.00436	CcSEcCtD
Vemurafenib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00425	CcSEcCtD
Vemurafenib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00425	CcSEcCtD
Vemurafenib—Vomiting—Colchicine—primary biliary cirrhosis	0.000438	0.00419	CcSEcCtD
Vemurafenib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000438	0.00419	CcSEcCtD
Vemurafenib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000438	0.00419	CcSEcCtD
Vemurafenib—Rash—Colchicine—primary biliary cirrhosis	0.000435	0.00415	CcSEcCtD
Vemurafenib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000434	0.00415	CcSEcCtD
Vemurafenib—Headache—Colchicine—primary biliary cirrhosis	0.000432	0.00413	CcSEcCtD
Vemurafenib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00405	CcSEcCtD
Vemurafenib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00405	CcSEcCtD
Vemurafenib—ABCG2—liver—primary biliary cirrhosis	0.000411	0.0188	CbGeAlD
Vemurafenib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000409	0.00391	CcSEcCtD
Vemurafenib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000409	0.00391	CcSEcCtD
Vemurafenib—Nausea—Colchicine—primary biliary cirrhosis	0.000409	0.00391	CcSEcCtD
Vemurafenib—CYP1A2—liver—primary biliary cirrhosis	0.000396	0.0181	CbGeAlD
Vemurafenib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00376	CcSEcCtD
Vemurafenib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00376	CcSEcCtD
Vemurafenib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00373	CcSEcCtD
Vemurafenib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00373	CcSEcCtD
Vemurafenib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00373	CcSEcCtD
Vemurafenib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00373	CcSEcCtD
Vemurafenib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00371	CcSEcCtD
Vemurafenib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00371	CcSEcCtD
Vemurafenib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000368	0.00351	CcSEcCtD
Vemurafenib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000368	0.00351	CcSEcCtD
Vemurafenib—CYP3A4—liver—primary biliary cirrhosis	0.000287	0.0131	CbGeAlD
Vemurafenib—CYP2D6—liver—primary biliary cirrhosis	0.000282	0.0129	CbGeAlD
Vemurafenib—RAF1—DAP12 interactions—CD80—primary biliary cirrhosis	7.46e-05	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—CD80—primary biliary cirrhosis	7.46e-05	0.00104	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	7.39e-05	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—CD80—primary biliary cirrhosis	7.39e-05	0.00103	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—CD80—primary biliary cirrhosis	7.34e-05	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—CD80—primary biliary cirrhosis	7.32e-05	0.00102	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—PDE5A—primary biliary cirrhosis	7.31e-05	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—CD80—primary biliary cirrhosis	7.29e-05	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—NFKB1—primary biliary cirrhosis	7.28e-05	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	7.27e-05	0.00102	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	7.23e-05	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—TYK2—primary biliary cirrhosis	7.22e-05	0.00101	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	7.2e-05	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	7.2e-05	0.00101	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	7.14e-05	0.000999	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—TYK2—primary biliary cirrhosis	7.11e-05	0.000995	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	7.04e-05	0.000985	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—TYK2—primary biliary cirrhosis	6.79e-05	0.00095	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—TYK2—primary biliary cirrhosis	6.76e-05	0.000945	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—TYK2—primary biliary cirrhosis	6.72e-05	0.000941	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—TYK2—primary biliary cirrhosis	6.69e-05	0.000936	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.65e-05	0.00093	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	6.61e-05	0.000925	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CD80—primary biliary cirrhosis	6.6e-05	0.000924	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.59e-05	0.000922	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	6.34e-05	0.000887	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—TYK2—primary biliary cirrhosis	6.29e-05	0.000881	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—TYK2—primary biliary cirrhosis	6.29e-05	0.000881	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—TYK2—primary biliary cirrhosis	6.29e-05	0.000881	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ELMO1—primary biliary cirrhosis	6.27e-05	0.000877	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	6.26e-05	0.000876	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—TYK2—primary biliary cirrhosis	6.24e-05	0.000873	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD3D—primary biliary cirrhosis	6.2e-05	0.000867	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—TYK2—primary biliary cirrhosis	6.2e-05	0.000867	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—TYK2—primary biliary cirrhosis	6.18e-05	0.000865	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	6.18e-05	0.000865	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—TYK2—primary biliary cirrhosis	6.16e-05	0.000861	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—OGDH—primary biliary cirrhosis	6.13e-05	0.000857	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	6.13e-05	0.000857	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	6.12e-05	0.000856	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—MMP9—primary biliary cirrhosis	5.95e-05	0.000832	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—NFKB1—primary biliary cirrhosis	5.81e-05	0.000813	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	5.8e-05	0.000811	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—NFKB1—primary biliary cirrhosis	5.78e-05	0.000809	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL7R—primary biliary cirrhosis	5.7e-05	0.000797	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—TYK2—primary biliary cirrhosis	5.57e-05	0.00078	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	5.56e-05	0.000778	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	5.53e-05	0.000773	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	5.52e-05	0.000772	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PDHX—primary biliary cirrhosis	5.46e-05	0.000764	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CDH5—primary biliary cirrhosis	5.43e-05	0.00076	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	5.43e-05	0.000759	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	5.41e-05	0.000757	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MAP3K14—primary biliary cirrhosis	5.4e-05	0.000756	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—OGDH—primary biliary cirrhosis	5.39e-05	0.000755	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	5.39e-05	0.000754	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NUP210—primary biliary cirrhosis	5.37e-05	0.000752	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCR5—primary biliary cirrhosis	5.23e-05	0.000731	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ABCB4—primary biliary cirrhosis	5.14e-05	0.000719	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—DLAT—primary biliary cirrhosis	5.14e-05	0.000719	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	5.11e-05	0.000715	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—CD80—primary biliary cirrhosis	5.08e-05	0.000711	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	4.9e-05	0.000686	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—NFKB1—primary biliary cirrhosis	4.83e-05	0.000676	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CTLA4—primary biliary cirrhosis	4.81e-05	0.000673	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PDHX—primary biliary cirrhosis	4.81e-05	0.000673	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—PPARGC1A—primary biliary cirrhosis	4.75e-05	0.000665	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL9—primary biliary cirrhosis	4.75e-05	0.000664	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	4.73e-05	0.000662	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ELMO1—primary biliary cirrhosis	4.7e-05	0.000657	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TAB1—primary biliary cirrhosis	4.69e-05	0.000656	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	4.68e-05	0.000654	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	4.62e-05	0.000646	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	4.61e-05	0.000646	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—LBR—primary biliary cirrhosis	4.6e-05	0.000644	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD79A—primary biliary cirrhosis	4.59e-05	0.000642	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ABCB4—primary biliary cirrhosis	4.52e-05	0.000632	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—DLAT—primary biliary cirrhosis	4.52e-05	0.000632	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ELMO1—primary biliary cirrhosis	4.39e-05	0.000614	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	4.38e-05	0.000613	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—TYK2—primary biliary cirrhosis	4.36e-05	0.00061	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ELMO1—primary biliary cirrhosis	4.34e-05	0.000607	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ELMO1—primary biliary cirrhosis	4.3e-05	0.000602	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—TYK2—primary biliary cirrhosis	4.29e-05	0.0006	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GOT2—primary biliary cirrhosis	4.25e-05	0.000594	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.21e-05	0.000589	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	4.08e-05	0.000571	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—MMP2—primary biliary cirrhosis	4.07e-05	0.000569	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NUP210—primary biliary cirrhosis	4.03e-05	0.000563	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.91e-05	0.000547	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—TYK2—primary biliary cirrhosis	3.88e-05	0.000543	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	3.8e-05	0.000532	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CDH5—primary biliary cirrhosis	3.76e-05	0.000526	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD40LG—primary biliary cirrhosis	3.74e-05	0.000523	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NUP210—primary biliary cirrhosis	3.72e-05	0.00052	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NUP210—primary biliary cirrhosis	3.69e-05	0.000516	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GOT1—primary biliary cirrhosis	3.67e-05	0.000513	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCR5—primary biliary cirrhosis	3.62e-05	0.000506	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	3.61e-05	0.000505	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	3.58e-05	0.000501	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—primary biliary cirrhosis	3.4e-05	0.000475	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—NFKB1—primary biliary cirrhosis	3.34e-05	0.000467	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—OGDH—primary biliary cirrhosis	3.33e-05	0.000466	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	3.33e-05	0.000465	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NOS2—primary biliary cirrhosis	3.32e-05	0.000464	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL9—primary biliary cirrhosis	3.28e-05	0.000459	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.28e-05	0.000459	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	3.22e-05	0.00045	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—NUP210—primary biliary cirrhosis	3.09e-05	0.000432	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—MMP9—primary biliary cirrhosis	3.06e-05	0.000428	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ELMO1—primary biliary cirrhosis	3.04e-05	0.000425	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3e-05	0.00042	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PDHX—primary biliary cirrhosis	2.97e-05	0.000415	CbGpPWpGaD
Vemurafenib—RAF1—Disease—GOT2—primary biliary cirrhosis	2.94e-05	0.000411	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTLA4—primary biliary cirrhosis	2.92e-05	0.000408	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GOT2—primary biliary cirrhosis	2.91e-05	0.000408	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—MMP2—primary biliary cirrhosis	2.9e-05	0.000406	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD80—primary biliary cirrhosis	2.9e-05	0.000405	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	2.89e-05	0.000405	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ABCG2—primary biliary cirrhosis	2.87e-05	0.000401	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ABCB4—primary biliary cirrhosis	2.79e-05	0.00039	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DLAT—primary biliary cirrhosis	2.79e-05	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ALB—primary biliary cirrhosis	2.79e-05	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD79A—primary biliary cirrhosis	2.78e-05	0.000389	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD80—primary biliary cirrhosis	2.78e-05	0.000389	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TYK2—primary biliary cirrhosis	2.77e-05	0.000387	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	2.75e-05	0.000384	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TAB1—primary biliary cirrhosis	2.73e-05	0.000382	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NUP210—primary biliary cirrhosis	2.72e-05	0.00038	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—MMP3—primary biliary cirrhosis	2.64e-05	0.000369	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.57e-05	0.000359	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HIF1A—primary biliary cirrhosis	2.55e-05	0.000357	CbGpPWpGaD
Vemurafenib—RAF1—Disease—GOT1—primary biliary cirrhosis	2.54e-05	0.000355	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.52e-05	0.000352	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GOT1—primary biliary cirrhosis	2.51e-05	0.000352	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL5—primary biliary cirrhosis	2.49e-05	0.000349	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	2.48e-05	0.000348	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.47e-05	0.000346	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CTGF—primary biliary cirrhosis	2.46e-05	0.000344	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	2.45e-05	0.000343	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TYK2—primary biliary cirrhosis	2.45e-05	0.000342	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GOT2—primary biliary cirrhosis	2.44e-05	0.000341	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.41e-05	0.000338	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.39e-05	0.000335	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	2.33e-05	0.000326	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS2—primary biliary cirrhosis	2.32e-05	0.000325	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	2.3e-05	0.000322	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	2.3e-05	0.000322	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.28e-05	0.00032	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD40LG—primary biliary cirrhosis	2.27e-05	0.000317	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MMP3—primary biliary cirrhosis	2.25e-05	0.000315	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD80—primary biliary cirrhosis	2.25e-05	0.000315	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—MMP9—primary biliary cirrhosis	2.18e-05	0.000305	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	2.17e-05	0.000303	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—NFKB1—primary biliary cirrhosis	2.16e-05	0.000302	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	2.15e-05	0.0003	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL5—primary biliary cirrhosis	2.13e-05	0.000298	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GOT1—primary biliary cirrhosis	2.11e-05	0.000295	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GGT1—primary biliary cirrhosis	2.11e-05	0.000295	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.1e-05	0.000294	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.1e-05	0.000294	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—AGT—primary biliary cirrhosis	2.08e-05	0.000292	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	2.07e-05	0.00029	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.06e-05	0.000289	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.95e-05	0.000273	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	1.95e-05	0.000273	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—NFKB1—primary biliary cirrhosis	1.91e-05	0.000267	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TYK2—primary biliary cirrhosis	1.9e-05	0.000266	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.87e-05	0.000262	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	1.85e-05	0.000259	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	1.85e-05	0.000259	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.83e-05	0.000256	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.8e-05	0.000251	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.8e-05	0.000251	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.79e-05	0.00025	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS2—primary biliary cirrhosis	1.78e-05	0.00025	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AGT—primary biliary cirrhosis	1.78e-05	0.000249	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.78e-05	0.000249	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HIF1A—primary biliary cirrhosis	1.76e-05	0.000247	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HIF1A—primary biliary cirrhosis	1.75e-05	0.000245	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.71e-05	0.000239	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD80—primary biliary cirrhosis	1.69e-05	0.000236	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NUP210—primary biliary cirrhosis	1.68e-05	0.000234	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.65e-05	0.000231	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS2—primary biliary cirrhosis	1.61e-05	0.000225	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.6e-05	0.000224	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.6e-05	0.000224	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS2—primary biliary cirrhosis	1.59e-05	0.000223	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CD80—primary biliary cirrhosis	1.58e-05	0.000221	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MMP3—primary biliary cirrhosis	1.56e-05	0.000218	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.56e-05	0.000218	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ABCG2—primary biliary cirrhosis	1.56e-05	0.000218	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD80—primary biliary cirrhosis	1.56e-05	0.000218	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD80—primary biliary cirrhosis	1.54e-05	0.000216	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.51e-05	0.000211	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.51e-05	0.000211	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL5—primary biliary cirrhosis	1.47e-05	0.000206	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AGT—primary biliary cirrhosis	1.46e-05	0.000204	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.43e-05	0.0002	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TYK2—primary biliary cirrhosis	1.42e-05	0.000199	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	1.38e-05	0.000194	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CTGF—primary biliary cirrhosis	1.34e-05	0.000187	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TYK2—primary biliary cirrhosis	1.33e-05	0.000186	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT2—primary biliary cirrhosis	1.32e-05	0.000185	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TYK2—primary biliary cirrhosis	1.31e-05	0.000184	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TYK2—primary biliary cirrhosis	1.3e-05	0.000182	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	1.29e-05	0.00018	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	1.28e-05	0.00018	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.24e-05	0.000174	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.24e-05	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AGT—primary biliary cirrhosis	1.23e-05	0.000172	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	1.17e-05	0.000164	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GGT1—primary biliary cirrhosis	1.14e-05	0.00016	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT1—primary biliary cirrhosis	1.14e-05	0.00016	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALB—primary biliary cirrhosis	1.12e-05	0.000157	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NFKB1—primary biliary cirrhosis	1.11e-05	0.000155	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	1.1e-05	0.000154	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	1.09e-05	0.000153	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CD80—primary biliary cirrhosis	1.09e-05	0.000153	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	1.09e-05	0.000152	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MMP9—primary biliary cirrhosis	1.05e-05	0.000147	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.04e-05	0.000145	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	1.02e-05	0.000142	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	9.86e-06	0.000138	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	9.55e-06	0.000134	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	9.44e-06	0.000132	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	9.44e-06	0.000132	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	9.35e-06	0.000131	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	9.27e-06	0.00013	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TYK2—primary biliary cirrhosis	9.21e-06	0.000129	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	9.05e-06	0.000127	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	8.41e-06	0.000118	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	8.4e-06	0.000118	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	8e-06	0.000112	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	8e-06	0.000112	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AGT—primary biliary cirrhosis	7.93e-06	0.000111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MMP9—primary biliary cirrhosis	7.25e-06	0.000101	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	7.22e-06	0.000101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.17e-06	0.0001	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	7.15e-06	0.0001	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	7.12e-06	9.96e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	6.54e-06	9.16e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	6.17e-06	8.64e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	6.17e-06	8.64e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	5.54e-06	7.76e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	5.49e-06	7.69e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	5.02e-06	7.03e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	4.28e-06	5.99e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	4.25e-06	5.95e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	3.28e-06	4.59e-05	CbGpPWpGaD
